Seth Ettenberg | BiotechTV

top of page

Search

BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress

BlueRock’s CEO on the Parkinson’s cell therapy data that was presented today at #MDSCongress

Seth Ettenberg describes safety, imaging, and efficacy takeaways from the 12-patient study.

Aug 28, 2023

Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO

Using a cell therapy as a potential treatment for Parkinson’s with BlueRock's CEO

CEO Seth Ettenberg explains how BlueRock is using pluripotent stems cells to try to restore dopamine production in Parkinson’s patients.

Jun 28, 2023

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page